Brief: Clearmind Medicine Announces Positive Permeation Results For Intranasal Meai Formulation
11/08/2026 14:06
BRIEF-Clearmind Medicine Announces Positive Permeation Results For Intranasal Meai Formulation Aug 11 (Reuters) - Clearmind Medicine Inc CMND.O:
CLEARMIND MEDICINE ANNOUNCES POSITIVE PERMEATION RESULTS FOR INTRANASAL MEAI FORMULATION, SUPPORTING ENHANCED NASAL RETENTION WITHOUT COMPROMISING DRUG DELIVERY
CLEARMIND MEDICINE - INTRANASAL MEAI SHOWS ENHANCED NASAL RETENTION WITHOUT COMPROMISING PERMEATION
CLEARMIND MEDICINE - INTRANASAL MEAI DEMONSTRATES SUBSTANTIALLY LONGER NASAL TISSUE RETENTION
Source text: ID:nGNX77wKzR
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM